2021
DOI: 10.1016/j.ejmech.2021.113633
|View full text |Cite
|
Sign up to set email alerts
|

Application of carbohydrates in approved small molecule drugs: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(21 citation statements)
references
References 231 publications
0
20
0
Order By: Relevance
“…3) Carbohydrates are an important energy source and play numerous key roles in all living organisms (Jiang et al, 2021). They are at high levels in residues of vegetable origin, especially starch, lignocellulose (cellulose, hemicellulose, and lignin), and βglucans, among others (Kumar et al, 2020).…”
Section: Bioactive Compoundsmentioning
confidence: 99%
“…3) Carbohydrates are an important energy source and play numerous key roles in all living organisms (Jiang et al, 2021). They are at high levels in residues of vegetable origin, especially starch, lignocellulose (cellulose, hemicellulose, and lignin), and βglucans, among others (Kumar et al, 2020).…”
Section: Bioactive Compoundsmentioning
confidence: 99%
“…Carbohydrates have been demonstrated to be involved in a variety of physiological events. Glycosylation modifications have received considerable attention from pharmaceutical chemists for their potential use in designing novel clinical drugs [ 23 ]. As both α- and β-CBD are insoluble in water, introducing carbohydrate residues into the parent cembrenediol could enhance the solubility of these compounds.…”
Section: Structural Modifications Of α- and β-Cbdmentioning
confidence: 99%
“…The gene cluster pax was identified as the first biosynthetic gene cluster of this family ( Tagami et al, 2013 ). Diabetes is a group of metabolic diseases characterized by hyperglycemia, which is caused by impaired peripheral glucose uptake and elevated hepatic glucose production ( Unger and Cherrington, 2012 ; Jiang et al, 2021 ). Enhanced glucagon response is proposed to be responsible for increased hepatic glucose production; it is proposed that suppression of hepatic glucagon response may provide therapeutic advantages in diabetes management ( Ozcan et al, 2012 ; Xiao et al, 2017 ).…”
Section: Introductionmentioning
confidence: 99%